Table 2.
Clinical characteristics of the Validation Cohort. Neurological signs in the table refer to those at the maximum follow-up
| Subject | Group | Sex | Age at EEG |
Age at Follow- Up |
Neurological Signs | MRI | ||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Seizures (onset) |
Dev Delay |
Stroke-Like Episodes |
Hemiparesis | Visual Field Cut | ||||||
| V-1 | NO-SWS | F | 4 mos. | 40 mos. | No | No | No | No | No | Negative at 4 mos. |
| V-2 | NO-SWS | M | 5 mos. | 37 mos. | No | No | No | No | No | Negative at 6 mos. |
| V-3 | NO-SWS | M | 4 mos. | 26 mos. | No | No | No | No | No | Negative at 19 mos. |
| V-4 | NO-SWS | F | 1 wk. | 24 mos. | No | No | No | No | No | Negative at 8 mos. |
| V-5 | SWS | M | 8 mos. | 36 mos. | Yes (4 mos.) | No | No | No | No | Positive at 4 mos. |
| V-6 | SWS | M | 5 mos. | 17 mos. | Yes (10 wks.) | Yes | No | Yes | Yes | Positive at 3 mos. |
| V-7 | SWS | F | 9 mos. | 32 mos. | No | Yes | No | Yes | Yes | Positive at 8 mos. |
| V-8 | SWS | M | 8 mos. | 24 mos. | Yes (4 mos.) | Yes | No | Yes | Yes | Positive at 4 mos. |
| V-9 | SWS | F | 2 mos. | 16 mos. | No | No | No | No | No | Positive at 1 mo. |